An Insider’s Look Into The Life Sciences Boom
tl;dr: The good times are still damn good for biotech. See, not all tech can’t IPO. Just most of it.
![Screen Shot 2016-04-20 at 2.53.12 PM](https://cdn-images-1.medium.com/max/1004/0*Tkxy5u-C_3_JNZqN.png)
These were the top 10 stories published by The Mattermark Daily in April of 2016. You can also dive into daily archives for April of 2016 by using the calendar at the top of this page.